Monoamine transporters in the brain structure and function

Handbook of Neurochemistry and Molecular Neurobiology: Neural Membranes and Transport

Volumn , Issue , 2007, Pages 339-362

  Sitte, H H ^a   Freissmuth, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878375220     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30380-2_17     Document Type: Chapter

References (168)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, et al. 2003. Structure and mechanism of the lactose permease of Escherichia coli. Science 301:610-615.
2. Accardi A, Miller C. 2004. Secondary active transport mediated by a prokaryotic homologue of ClC Cl-channels. Nature 427:803-807.
3. Adams SV, DeFelice LJ. 2002. Flux coupling in the human serotonin transporter. Biophys J 83:3268-3282.
4. Adams SV, DeFelice LJ. 2003. Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85:1548-1559.
5. Amara SG, Kuhar MJ. 1993. Neurotransmitter transporters: Recent progress. Annu Rev Neurosci 16:73-93.
6. Androutsellis-Theotokis A, Ghassemi F, Rudnick G. 2001. A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter. J Biol Chem 276:45933-45938.
7. Androutsellis-Theotokis A, Goldberg NR, Ueda K, Beppu T, Beckman ML, et al. 2003. Characterization of a functional bacterial homologue of sodium-dependent neurotransmit-ter transporters. J Biol Chem 278:12703-12709.
8. Androutsellis-Theotokis A, Rudnick G. 2002. Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 22:8370-8378.
9. Axelrod J. 1971. Noradrenaline: Fate and control of its biosynthesis. Science 173:598-606.
10. Axelrod J, Whitby LG, Hertting G. 1961. Effect of psychotro-pic drugs on the uptake of 3H-norepinephrine by tissues. Science 133:383-384.
11. Beckman ML, Quick MW. 2001. Substrates and temperature differentiate ion flux from serotonin flux in a serotonin transporter. Neuropharmacology 40:526-535.
12. Bendahan A, Kanner BI. 1993. Identification of domains of a cloned rat brain GABA transporter which are not required for its functional expression. FEBS Lett 318:41-44.
13. Berfield JL, Wang LC, Reith ME. 1999. Which form of dopa-mine is the substrate for the human dopamine transporter: The cationic or the uncharged species? J Biol Chem 274:4876-4882.
14. Birkmayer W, Hornykiewicz O. 1961. The L-3, 4-dioxypheny-lalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73:787-788.
15. Bönisch H, Trendelenburg U. 1989. The mechanism of action of indirectly acting sympathomimetic amines. Handbook of Experimental Pharmacology: Catecholamines. Trende-lenburg U, Weiner N, editors. Berlin, Hamburg, New York: Springer; pp. 247-277.
16. Browman KE, Kantor L, Richardson S, Badiani A, Robinson TE, et al. 1998. Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: Tissue and behavioral studies. Brain Res 814:112-119.
17. Bruns D, Engert F, Lux H-D. 1993. A fast activating presynap-tic reuptake current during serotonergic transmission in identified neurons of Hirudo. Neuron 10:559-572.
18. Bruss M, Hammermann R, Brimijoin S, Bonisch H. 1995. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 270:9197-9201.
19. Busch W, Saier MH Jr. 2002. The transporter classification (TC) system, 2002. Crit Rev Biochem Mol Biol 37:287-337.
20. Cao Y, Li M, Mager S, Lester HA. 1998. Amino acid residues that control pH modulation of transport-associated current in mammalian serotonin transporters. J Neurosci 18:7739-7749.
21. + permeation and pH regulation at a mammalian serotonin transporter. J Neurosci 17:2257-2266.
22. Carlsson A. 2001. A half-century of neurotransmitter research: Impact on neurology and psychiatry (Nobel lecture). Chembiochem 2:484-493.
23. Carvelli L, McDonald PW, Blakely RD, DeFelice LJ. 2004. Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci USA 101:16046-16051.
24. Chen F, Larsen MB, Neubauer HA, Sanchez C, Plenge P, et al. 2005. Characterization of an allosteric citalopram-binding site at the serotonin transporter. J Neurochem 92:21-28.
25. Chen JG, Liu CS, Rudnick G. 1997. External cysteine residues in the serotonin transporter. Biochemistry 36:1479-1486.
26. Chen JG, Liu CS, Rudnick G. 1998. Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 273:12675-12681.
27. Chen N, Reith ME. 2000. Structure and function of the dopamine transporter. Eur J Pharmacol 405:329-339.
28. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, et al. 1995. The dopamine transporter: Immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
29. Cool DR, Leibach FH, Bhalla VK, Mahesh VB, Ganapathy V. 1991. Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human pla-cental choriocarcinoma cell line (JAR). J Biol Chem 266:15750-15757.
30. 2+ pump of cardiac sarcoplasmic reticulum. J Biol Chem 275:41487-41494.
31. Dale H. 1935. Reizübertragung durch chemische Mittel im peripheren Nervensystem. Urban and Schwarzenberg. Berlin: Wien; pp. 1-23.
32. DeFelice LJ, Adams SV, Ypey DL. 2001. Single-file diffusion and neurotransmitter transporters: Hodgkin and Keynes model revisited. Biosystems 62:57-66.
33. DeFelice LJ, Blakely RD. 1996. Pore models for transporters? Biophys J 70:579-580.
34. DeFelice LJ, Galli A. 1998. Electrophysiological analysis of transporter function. Adv Pharmacol 42:186-190.
35. Distelmaier F, Wiedemann P, Bruss M, Bonisch H. 2004. Functional importance of the C-terminus of the human norepinephrine transporter. J Neurochem 91:537-546.
36. Eisenhofer G. 2001. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35-62.
37. Ellgaard L, Helenius A. 2003. Quality control in the endoplas-mic reticulum. Nat Rev Mol Cell Biol 4:181-191.
38. Elling CE, Nielsen SM, Schwartz TW. 1995. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Nature 374:74-77.
39. Elling CE, Schwartz TW. 1996. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. EMBO J 15:6213-6219.
40. Falkenburger BH, Barstow KL, Mintz IM. 2001. Dendroden-dritic inhibition through reversal of dopamine transport. Science 293:2465-2470.
41. Farhan H, Korkhov VM, Paulitschke V, Dorostkar MM, Scholze P, et al. 2004. Two discontinuous segments in the carboxy terminus are required for membrane targeting of the rat GABA transporter-1 (GAT1). J Biol Chem 279:28553-28563.
42. Ferrer JV, Javitch JA. 1998. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc Natl Acad Sci USA 95:9238-9243.
43. Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U. 2006. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51:417-429.
44. Forster R, Weiss M, Zimmermann T, Reynaud EG, Verissimo F, et al. 2006. Secretory cargo regulates the turnoverof COPII subunits at single ER exit sites. Curr Biol 16:173-179.
45. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, et al. 1995. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340-349.
46. Galli A, Blakely RD, DeFelice LJ. 1996. Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 93:8671-8676.
47. Galli A, Blakely RD, DeFelice LJ. 1998. Patch-clamp and amperometric recordings from norepinephrine transporters: Channel activity and voltage-dependent uptake. Proc Natl Acad Sci USA 95:13260-13265.
48. Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD. 1995. Sodium-dependent norepinephrine-induced currents in nor-epinephrine-transporter- transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198:2197-2212.
49. Gether U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113.
50. + binding sites. Life Sci 68:2187-2198.
51. Giros B, el Mestikawy S, Bertrand L, Caron MG. 1991. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154.
52. Gnegy ME. 2003. The effect of phosphorylation on amphetamine-mediated outward transport. Eur J Pharmacol 479:83-91.
53. Graham D, Esnaud H, Langer SZ. 1991. Characterization and purification of the neuronal sodium-ion-coupled 5-hydroxytryptamine transporter. Biochem Soc Trans 19:99-102.
54. Graham D, Esnaud H, Langer SZ. 1992. Partial purification and characterization of the sodium-ion-coupled 5-hydroxytryptamine transporter of rat cerebral cortex. Biochem J 286(Pt. 3):801-805.
55. Granas C, Ferrer J, Loland CJ, Javitch JA, Gether U. 2003. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter inter-nalization. J Biol Chem 278:4990-5000.
56. Gu HH, Ahn J, Caplan MJ, Blakely RD, Levey AI, et al. 1996a. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J Biol Chem 271:18100-18106.
57. Gu HH, Wall S, Rudnick G. 1996b. Ion coupling stoichiometry for the norepinephrine transporter in membrane vesicles from stably transfected cells. J Biol Chem 271:6911-6916.
58. Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, et al. 1990. Cloning and expression of a rat brain GABA transporter. Science 249:1303-1306.
59. Habert E, Graham D, Langer SZ. 1986. Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes. Eur J Pharmacol 122:197-204.
60. Hahn MK, Robertson D, Blakely RD. 2003. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478.
61. Harata NC, Choi S, Pyle JL, Aravanis AM, Tsien RW. 2006. Frequency-dependent kinetics and prevalence of kiss-and-run and reuse at hippocampal synapses studied with novel quenching methods. Neuron 49:243-256.
62. Hastrup H, Karlin A, Javitch JA. 2001. Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc Natl Acad Sci USA 98:10055-10060.
63. Hebert DN, Carruthers A. 1992. Glucose transporter oligo-meric structure determines transporter function. Reversible redox-dependent interconversions of tetrameric and di-meric GLUT1. J Biol Chem 267:23829-23838.
64. Heldin CH. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
65. Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH. 2005. Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49:811-819.
66. Hoffman BJ, Palkovits M, Pacak K, Hansson SR, Mezey E. 1998. Regulation of dopamine transporter mRNA levels in the central nervous system. Adv Pharmacol 42:202-206.
67. Horiuchi M, Nicke A, Gomeza J, Aschrafi A, Schmalzing G, et al. 2001. Surface-localized glycine transporters 1and2 function as monomeric proteins in Xenopus oocytes. Proc Natl Acad Sci USA 98:1448-1453.
68. Horschitz S, Hummerich R, Schloss P. 2003. Functional coupling of serotonin and noradrenaline transporters. J Neurochem 86:958-965.
69. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN. 2003. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301:616-620.
70. Humphreys CJ, Wall SC, Rudnick G. 1994. Ligand binding to the serotonin transporter: Equilibria, kinetics, and ion dependence. Biochemistry 33:9118-9125.
71. Ingram SL, Prasad BM, Amara SG. 2002. Dopamine transporter-mediated conductances increase excitability of mid-brain dopamine neurons. Nat Neurosci 5:971-978.
72. Iversen L. 2000. Neurotransmitter transporters: Fruitful targets for CNS drug discovery. Mol Psychiatry 5:357-362.
73. Jardetzky O. 1966. Simple allosteric model for membrane pumps. Nature 211:969-970.
74. Just H, Sitte HH, Schmid JA, Freissmuth M, Kudlacek O. 2004. Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligo-mer formation in the human serotonin transporter. J Biol Chem 279:6650-6657.
75. Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, et al. 2005. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102:3495-3500.
76. +, and methanethiosulfonate reagents. J Biol Chem 276:4038-4045.
77. Kantor L, Gnegy ME. 1998. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598.
78. Kantor L, Hewlett GH, Park YH, Richardson-Burns SM, Mellon MJ, et al. 2001. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopa-mine release via the norepinephrine transporter in undif-ferentiated PC12 cells. J Pharmacol Exp Ther 297:1016-1024.
79. Karlin A, Akabas MH. 1998. Substituted-cysteine accessibility method. Methods Enzymol 293:123-145.
80. Keyes SR, Rudnick G. 1982. Coupling of transmembrane proton gradients to platelet serotonin transport. J Biol Chem 257:1172-1176.
81. Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, et al. 2004. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2:E78.
82. Kocabas AM, Rudnick G, Kilic F. 2003. Functional consequences of homo-but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J Neurochem 85:1513-1520.
83. Korkhov VM, Farhan H, Freissmuth M, Sitte HH. 2004. Oligomerization of the {gamma}-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II. J Biol Chem 279:55728-55736.
84. Korkhov VM, Holy M, Freissmuth M, Sitte HH. 2006. The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the confor-mational switch in the transport cycle. J Biol Chem 281:13439-13448.
85. Kuhar MJ, Ritz MC, Boja JW. 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
86. Launay JM, Geoffroy C, Mutel V, Buckle M, Cesura A, et al. 1992. One-step purification of the serotonin transporter located at the human platelet plasma membrane. J Biol Chem 267:11344-11351.
87. Lester HA, Cao Y, Mager S. 1996. Listening to neurotransmit-ter transporters. Neuron 17:807-810.
88. Lester HA, Mager S, Quick MW, Corey JL. 1994. Permeation properties of neurotransmitter transporters. Annu Rev Pharmacol Toxicol 34:219-249.
89. Levi G, Raiteri M. 1993. Carrier-mediated release of neuro-transmitters. Trends Neurosci 16:415-419.
90. + toxicity encodes a vesicular amine transporter. Cell 70:539-551.
91. (2+) inding site. J Biol Chem 274:36928-36934.
92. Lopez-Corcuera B, Alcantara R, Vazquez J, Aragon C. 1993. Hydrodynamic properties and immunological identification of the sodium- and chloride-coupled glycine transporter. J Biol Chem 268:2239-2243.
93. MacKenzie KR, Engelman DM. 1998. Structure-based prediction of the stability of transmembrane helix-helix interactions: The sequence dependence of glycophorin A dimerization. Proc Natl Acad Sci USA 95:3583-3590.
94. MacKinnon R. 2003. Potassium channels. FEBS Lett 555:62-65.
95. Mager S, Min C, Henry DJ, Chavkin C, Hoffman BJ, et al. 1994. Conducting states of a mammalian serotonin transporter. Neuron 12:845-859.
96. Meinild AK, Sitte HH, Gether U. 2004. Zinc potentiates an uncoupled anion conductance associated with the dopa-mine transporter. J Biol Chem 279:49671-49679.
97. Mezey E, Eisenhofer G, Hansson S, Hunyady B, Hoffman BJ. 1998. Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat. Neuroendocrinology 67:336-348.
98. Miller EA, Beilharz TH, Malkus PN, Lee MC, Hamamoto S, et al. 2003. Multiple cargo binding sites on the COPII subunit Sec24p ensure capture of diverse membrane proteins into transport vesicles. Cell 114:497-509.
99. Miranda M, Sorkina T, Grammatopoulos TN, Zawada WM, Sorkin A. 2004. Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. J Biol Chem 279:30760-30770.
100. Mossessova E, Bickford LC, Goldberg J. 2003. SNARE selectivity of the COPII coat. Cell 114:483-495.
101. Nelson PJ, Rudnick G. 1979. Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem 254:10084-10089.
102. Nelson PJ, Rudnick G. 1982. The role of chloride ion in platelet serotonin transport. J Biol Chem 257:6151-6155.
103. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, et al. 1997a. The dopamine transporter: Comparative ul-trastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
104. Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, et al. 1997b. Immunogold localization of the dopamine transporter: An ultrastructural study of the rat ventral tegmental area. J Neurosci 17:5255-5262.
105. Norregaard L, Frederiksen D, Nielsen EO, Gether U. 1998. Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J 17:4266-4273.
106. 2+ binding sites. Biochemistry 39:15836-15846.
107. Orci L, Ravazzola M, Meda P, Holcomb C, Moore HP, et al. 1991. Mammalian Sec23p homologue is restricted to the endoplasmic reticulum transitional cytoplasm. Proc Natl Acad Sci USA 88:8611-8615.
108. Pacholczyk T, Blakely RD, Amara SG. 1991. Expression cloning of a cocaine- and antidepressant-sensitive human nor-adrenaline transporter. Nature 350:350-354.
109. Perego C, Bulbarelli A, Longhi R, Caimi M, Villa A, et al. 1997. Sorting of two polytopic proteins, the gamma-aminobutyric acid and betaine transporters, in polarized epithelial cells. J Biol Chem 272:6584-6592.
110. Petersen CI, DeFelice LJ. 1999. Ionic interactions in the Dro-sophila serotonin transporter identify it as a serotonin channel. Nat Neurosci 2:605-610.
111. Popot JL, Engelman DM. 1990. Membrane protein folding and oligomerization: The two-stage model. Biochemistry 29:4031-4037.
112. Popot JL, Engelman DM. 2000. Helical membrane protein folding, stability, and evolution. Annu Rev Biochem 69:881-922.
113. Pothos EN, Sulzer D. 1998. Modulation of quantal dopamine release by psychostimulants. Adv Pharmacol 42:198-202.
114. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, et al. 1997. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
115. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD. 1995. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15:1261-1274.
116. Quick MW. 2003. Regulating the conducting states of a mammalian serotonin transporter. Neuron 40:537-549.
117. Ramamoorthy S, Blakely RD. 1999. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
118. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang FT, et al. 1993a. Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
119. Ramamoorthy S, Cool DR, Leibach FH, Mahesh VB, Ganapathy V. 1992. Reconstitution of the human placental 5-hydroxytryptamine transporter in a catalytically active form after detergent solubilization. Biochem J 286(Pt. 1):89-95.
120. Ramamoorthy S, Leibach FH, Mahesh VB, Ganapathy V. 1993b. Partial purification and characterization of the human placental serotonin transporter. Placenta 14:449-461.
121. Rasmussen SG, Carroll FI, Maresch MJ, Jensen AD, Tate CG, et al. 2001. Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter. J Biol Chem 276:4717-4723.
122. Reddy LG, Jones LR, Thomas DD. 1999. Depolymerization of phospholamban in the presence of calcium pump: A fluorescence energy transfer study. Biochemistry 38:3954-3962.
123. Reith ME, Berfield JL, Wang LC, Ferrer JV, Javitch JA. 2001. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-29018.
124. Rudnick G. 2002. Mechanism of biogenic amine neurotrans-mitter transporters. Neurotransmitter Transporters: Structure, Function, and Regulation. Reith MEA, editor. Totowa, NJ: Humana Press Inc.; pp. 25-52.
125. Rudnick G. 2006. Structure/function relationship in serotonin transporter. Neurotransmitter Transporters. Sitte HH, Freissmuth M, editors. Berlin, Heidelberg: Springer-Verlag; pp. 59-73.
126. Rudnick G, Clark J. 1993. From synapse to vesicle: The reup-take and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249-263.
127. Rudnick G, Kirk KL, Fishkes H, Schuldiner S. 1989. Zwitter-ionic and anionic forms of a serotonin analog as transport substrates. J Biol Chem 264:14865-14868.
128. Sanchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, et al. 2003. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) 167:353-362.
129. Sato K, Nakano A. 2004. Reconstitution of coat protein complex II (COPII) vesicle formation from cargo-reconstituted proteoliposomes reveals the potential role of GTP hydrolysis by Sar1p in protein sorting. J Biol Chem 279:1330-1335.
130. Sato K, Nakano A. 2005. Dissection of COPII subunit-cargo assembly and disassembly kinetics during Sar1p-GTP hydrolysis. Nat Struct Mol Biol 12:167-174.
131. Schmid JA, Just H, Sitte HH. 2001a. Impact of oligomeriza-tion on the function of the human serotonin transporter. Biochem Soc Trans 29:732-736.
132. Schmid JA, Scholze P, Kudlacek O, Freissmuth M, Singer EA, et al. 2001b. Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J Biol Chem 276:3805-3810.
133. Scholze P, Freissmuth M, Sitte HH. 2002. Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J Biol Chem 277:43682-43690.
134. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR., et al. 2000. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420:211-232.
135. Schroeter S, Levey AI, Blakely RD. 1997. Polarized expression of the antidepressant-sensitive serotonin transporter in epi-nephrine-synthesizing chromaffin cells of the rat adrenal gland. Mol Cell Neurosci 9:170-184.
136. Seidel S, Singer EA, Just H, Farhan H, Scholze P, et al. 2005. Amphetamines take two to tango: An oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol 67:140-151.
137. Seiden LS, Sabol KE, Ricaurte GA. 1993. Amphetamine: Effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639-677.
138. Sen N, Shi L, Beuming T, Weinstein H, Javitch JA. 2005. A pincer-like configuration of TM2 in the human dopa-mine transporter is responsible for indirect effects on cocaine binding. Neuropharmacology 49:780-790.
139. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, et al. 2000. Orthostatic intolerance and tachycardia associated with norepinephrine- transporter deficiency. N Engl J Med 342:541-549.
140. Sitte HH, Farhan H, Javitch JA. 2004. Sodium-dependent neurotransmitter transporters: Oligomerization as a determinant of transporter function and trafficking. Mol Intervent 4:38-47.
141. + Cl-coupled neurotransmitter transporters. Eur J Pharmacol 479:229-236.
142. Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, et al. 2001. Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: Inconsistencies with the hypothesis of facilitated exchange diffusion. Mol Pharmacol 59:1129-1137.
143. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, et al. 1998. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297.
144. Sonders MS, Amara SG. 1996. Channels in transporters. Curr Opin Neurobiol 6:294-302.
145. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG. 1997. Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimu-lants. J Neurosci 17:960-974.
146. Sorkina T, Doolen S, Galperin E, Zahniser NR, Sorkin A. 2003. Oligomerization of dopamine transporters visualized in living cellsbyFRETmicroscopy. JBiol Chem 278:28274-28283.
147. Stagg SM, Gurkan C, Fowler DM, LaPointe P, Foss TR, et al. 2006. Structure of the Sec13/31 COPII coat cage. Nature 439:234-238.
148. Sugamori KS, Lee FJ, Pristupa ZB, Niznik HB. 1999. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line. FEBS Lett 451:169-174.
149. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, et al. 1995. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
150. Sulzer D, Galli A. 2003. Dopamine transport currents are promoted from curiosity to physiology. Trends Neurosci 26:173-176.
151. Sulzer D, Rayport S. 1990. Amphetamine and other psychos-timulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of action. Neuron 5:797-808.
152. Sulzer D, Rayport S. 2000. Dale's principle and glutamate corelease from ventral midbrain dopamine neurons. Amino Acids 19:45-52.
153. Sulzer D, Sonders MS, Poulsen NW, Galli A. 2005. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75:406-433.
154. Sur C, Betz H, Schloss P. 1996. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73:217-231.
155. Sur C, Betz H, Schloss P. 1998. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediatedby the recombinant rat serotonin transporter SERT1. J Neurochem 70:2545-2553.
156. Swanson JM, Volkow ND. 2003. Serum and brain concentrations of methylphenidate: Implications for use and abuse. Neurosci Biobehav Rev 27:615-621.
157. Talvenheimo J, Fishkes H, Nelson PJ, Rudnick G. 1983. The serotonin transporter-imipramine "receptor". J Biol Chem 258:6115-6119.
158. Talvenheimo J, Nelson PJ, Rudnick G. 1979. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem 254:4631-4635.
159. Tate CG, Haase J, Baker C, Boorsma M, Magnani F, et al. 2003. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim Biophys Acta 1610:141-153.
160. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, et al. 2003. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278:2731-2739.
161. Trendelenburg U, Langeloh A, Bönisch H. 1987. Mechanism of action of indirectly acting sympathomimetic amines. Blood Vessels 24:261-270.
162. White SH, Wimley WC. 1999. Membrane protein folding and stability: Physical principles. Annu Rev Biophys Biomol Struct 28:319-365.
163. +/Cl-depen-dent neurotransmitter transporters. Nature 437:215-223.
164. Yernool D, Boudker O, Jin Y, Gouaux E. 2004. Structure of a glutamate transporter homologue from Pyrococcus hori-koshii. Nature 431:811-818.
165. Youvan DC, Silva CM, Bylina EJ, Coleman WJ, Dilworth MR, et al. 1997. Calibration of fluorescence resonance energy transfer in microscopy using genetically engineered GFP derivatives on nickel chelating beads. Biotechnology et alia 3:1-18.
166. Zaczek R, Culp S, De SE. 1991. Interactions of [3H]amphet-amine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 257:830-835.
167. Zhang DQ, Stone JF, Zhou T, Ohta H, McMahon DG. 2004. Characterization of genetically labeled catecholamine neurons in the mouse retina. Neuroreport 15:1761-1765.
168. Zhou FX, Merianos HJ, Brunger AT, Engelman DM. 2001. Polar residues drive association of polyleucine transmem-brane helices. Proc Natl Acad Sci USA 98:2250-2255.